Identification of key pathways and genes in TP53 mutation acute myeloid leukemia: evidence from bioinformatics analysis

BACKGROUND: Tumor protein p53 (TP53) mutations are not only a risk factor in acute myeloid leukemia (AML) but also a potential biomarker for individualized treatment options. This study aimed to investigate potential pathways and genes associated with TP53 mutations in adult de novo AML. METHODS: An...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Rui, Liao, Xiwen, Li, Qiaochuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749383/
https://www.ncbi.nlm.nih.gov/pubmed/29343974
http://dx.doi.org/10.2147/OTT.S156003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749383/
https://www.ncbi.nlm.nih.gov/pubmed/29343974
http://dx.doi.org/10.2147/OTT.S156003

Ejemplares similares